Edition:
United States

People: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

3.45USD
24 Jul 2017
Change (% chg)

$0.30 (+9.52%)
Prev Close
$3.15
Open
$3.20
Day's High
$3.50
Day's Low
$3.15
Volume
900,368
Avg. Vol
552,952
52-wk High
$4.08
52-wk Low
$1.95

Edwards, Mark 

Mr. Mark G. Edwards is Independent Director of AcelRx Pharmaceuticals, Inc. Mr. Edwards is Managing Director of Bioscience Advisors Inc., a biopharmaceutical consulting firm he founded in 2011. From July 2008 until December 2010, he was Managing Director and a Principal of Deloitte Recap LLC, a wholly-owned subsidiary of Deloitte Touche Tohmatsu, an audit and financial consulting services firm. Mr. Edwards was previously the Managing Director and founder of Recombinant Capital, Inc. (Recap), a consulting and database firm based in Walnut Creek, California, from 1988 until the sale of Recap to Deloitte in 2008. Prior to founding Recap in 1988, Mr. Edwards was Manager of Business Development at Chiron Corporation, a biotechnology company. He received his B.A. and M.B.A. degrees from Stanford University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adrian Adams

--

Richard King

2,030,280

Vincent Angotti

--

Pamela Palmer

1,661,310

Badri Dasu

1,079,640

Lawrence Hamel

1,077,470
As Of  30 Dec 2014